HYDROPROGRESS 250

HYDROPROGRESS 250 is a long-acting sterile injectable formulation containing Hydroxyprogesterone Injection IP 250 mg, designed specifically to support women with high-risk pregnancies. Manufactured under strict WHO-GMP standards by Steris Healthcare Pvt. Ltd., this product is a reliable therapeutic option for preventing preterm labor and managing progesterone deficiency-related conditions.Progesterone is vital for maintaining a healthy pregnancy, and hydroxyprogesterone injection mimics the natural hormone to strengthen the uterine lining and reduce uterine contractions. Trusted by obstetricians and gynecologists across India, HYDROPROGRESS 250 ensures both maternal and fetal health in vulnerable pregnancies.

What is Hydroxyprogesterone Injection IP 250 mg?

Hydroxyprogesterone is a synthetic form of the hormone progesterone, which plays a crucial role in maintaining pregnancy. Hydroxyprogesterone injection IP 250 mg is administered intramuscularly to support gestation in women with a history of premature deliveries or hormonal imbalances. It provides a sustained hormone release to stabilize the pregnancy and prevent early labor.

Hydroxyprogesterone Injection Use

The main hydroxyprogesterone injection use includes:

• Prevention of Preterm Birth: Especially in women with a history of spontaneous preterm delivery.

• Hormonal Support During Pregnancy: In cases of luteal phase defects or inadequate natural progesterone.

• Recurrent Miscarriage Management: Helps sustain early pregnancies in women with prior miscarriage history.

• Support in Assisted Reproductive Technology (ART): Often used during IVF or IUI cycles to enhance uterine receptivity.

Hydroxyprogesterone Injection Side Effects

Like any medication, hydroxyprogesterone injection may cause side effects in some individuals. These include:

• Pain, swelling, or redness at the injection site

• Headache or dizziness

• Nausea or vomiting

• Breast tenderness

• Mood swings or irritability

• Rash, itching, or allergic reaction (rare)

• Shortness of breath (very rare but serious)

These hydroxyprogesterone injection side effects are usually mild and resolve with continued use. However, any unusual or severe reactions should be reported to a healthcare professional immediately.

Precautions Before Using Hydroxyprogesterone Injection IP 250 mg

Before starting HYDROPROGRESS 250, inform your doctor if:

• You have liver disease or abnormal liver function tests

• You have or had breast cancer or hormone-sensitive tumors

• You have a history of blood clots (thrombosis), stroke, or cardiovascular disease

• You are experiencing undiagnosed vaginal bleeding

• You are allergic to progesterone or any injection component

This medication should not be used for conditions unrelated to pregnancy support or in postmenopausal women.

Hydroxyprogesterone Injection Dose

The recommended hydroxyprogesterone injection dose is:

• 250 mg, administered once weekly via intramuscular injection

• Treatment typically begins during the second trimester (around 16–20 weeks) and continues until week 36 or 37 of gestation

Dosage and schedule must be strictly followed as per your healthcare provider's instructions for optimal effectiveness.

Drug Interactions: What Drugs Interact with Hydroxyprogesterone Injection?

Hydroxyprogesterone may interact with certain drugs that induce liver enzymes or alter hormone metabolism, such as:

• Rifampicin

• Carbamazepine

• Phenytoin

• Phenobarbital

• St. John's Wort (herbal supplement)

These interactions may reduce the effectiveness of hydroxyprogesterone injection IP 250 mg. Always inform your doctor about all medications, supplements, or herbal remedies you are using.

Conclusion

HYDROPROGRESS 250, powered by hydroxyprogesterone injection IP 250 mg, is an effective solution to support and sustain pregnancy, especially in women at high risk of preterm birth or hormonal deficiency. Developed by Steris Healthcare Pvt. Ltd., a trusted name in Indian pharmaceuticals, this product stands out for its quality, consistency, and affordability.